المؤلفون: Rimini M., Yoo C., Lonardi S., Masi G., Granito A., Bang Y., Rizzato M. D., Vivaldi C., Ielasi L., Kim H. -D., Bergamo F., Salani F., Leoni S., Ryoo B. -Y., Ryoo M. -H., Burgio V., Cascinu S., Casadei-Gardini A.

المساهمون: Rimini, M., Yoo, C., Lonardi, S., Masi, G., Granito, A., Bang, Y., Rizzato, M. D., Vivaldi, C., Ielasi, L., Kim, H. -D., Bergamo, F., Salani, F., Leoni, S., Ryoo, B. -Y., Ryoo, M. -H., Burgio, V., Cascinu, S., Casadei-Gardini, A.

مصطلحات موضوعية: Humans, Phenylurea Compounds, Prognosis, Pyridines, Carcinoma, Hepatocellular, Liver Neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000693704500001; volume:16; issue:5; firstpage:653; lastpage:661; numberofpages:9; journal:TARGETED ONCOLOGY; http://hdl.handle.net/20.500.11768/125256Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85114333126

الإتاحة: https://doi.org/20.500.11768/125256Test
https://doi.org/10.1007/s11523-021-00834-1Test
https://hdl.handle.net/20.500.11768/125256Test

المؤلفون: Rapposelli I. G., Shimose S., Kumada T., Okamura S., Hiraoka A., Di Costanzo G. G., Marra F., Tamburini E., Forgione A., Foschi F. G., Silletta M., Lonardi S., Masi G., Scartozzi M., Nakano M., Shibata H., Kawata K., Pellino A., Vivaldi C., Lai E., Takata A., Tajiri K., Toyoda H., Tortora R., Campani C., Viola M. G., Piscaglia F., Conti F., Fulgenzi C. A. M., Frassineti G. L., Rizzato M. D., Salani F., Astara G., Torimura T., Atsukawa M., Tada T., Burgio V., Rimini M., Cascinu S., Casadei-Gardini A.

المساهمون: Rapposelli, I. G., Shimose, S., Kumada, T., Okamura, S., Hiraoka, A., Di Costanzo, G. G., Marra, F., Tamburini, E., Forgione, A., Foschi, F. G., Silletta, M., Lonardi, S., Masi, G., Scartozzi, M., Nakano, M., Shibata, H., Kawata, K., Pellino, A., Vivaldi, C., Lai, E., Takata, A., Tajiri, K., Toyoda, H., Tortora, R., Campani, C., Viola, M. G., Piscaglia, F., Conti, F., Fulgenzi, C. A. M., Frassineti, G. L., Rizzato, M. D., Salani, F., Astara, G., Torimura, T., Atsukawa, M., Tada, T., Burgio, V., Rimini, M., Cascinu, S., Casadei-Gardini, A.

مصطلحات موضوعية: hepatocellular carcinoma, lenvatinib prognostic index, recursive partitioning analysis, Humans, Phenylurea Compounds, Prognosis, Quinolines, Carcinoma, Hepatocellular, Chemoembolization, Therapeutic, Liver Neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000703610200025; volume:6; issue:4; firstpage:100190; journal:ESMO OPEN; http://hdl.handle.net/20.500.11768/125261Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85117623332

الإتاحة: https://doi.org/20.500.11768/125261Test
https://doi.org/10.1016/j.esmoop.2021.100190Test
https://hdl.handle.net/20.500.11768/125261Test

المؤلفون: Bang Y., Yoo C., Lonardi S., Kim H. -D., Vivaldi C., Rimini M., Frassineti G. L., Park S. R., Rizzato M. D., Ryu M. -H., Salani F., Rapposelli I. G., Ryoo B. -Y., Zagonel V., Massa V., Valgiusti M., Burgio V., Scartozzi M., Cascinu S., Casadei-Gardini A.

المساهمون: Bang, Y., Yoo, C., Lonardi, S., Kim, H. -D., Vivaldi, C., Rimini, M., Frassineti, G. L., Park, S. R., Rizzato, M. D., Ryu, M. -H., Salani, F., Rapposelli, I. G., Ryoo, B. -Y., Zagonel, V., Massa, V., Valgiusti, M., Burgio, V., Scartozzi, M., Cascinu, S., Casadei-Gardini, A.

مصطلحات موضوعية: Antineoplastic Combined Chemotherapy Protocols, Carcinoma, Hepatocellular, Female, Humans, Liver Neoplasms, Male, Phenylurea Compounds, Pyridines, Retrospective Studies, Sorafenib, Propensity Score

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000623729800001; volume:16; issue:3; firstpage:401; lastpage:410; numberofpages:10; journal:TARGETED ONCOLOGY; http://hdl.handle.net/20.500.11768/125270Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101838504

الإتاحة: https://doi.org/20.500.11768/125270Test
https://doi.org/10.1007/s11523-021-00797-3Test
https://hdl.handle.net/20.500.11768/125270Test

المؤلفون: Casadei-Gardini A., Scartozzi M., Tada T., Yoo C., Shimose S., Masi G., Lonardi S., Frassineti L. G., Nicola S., Piscaglia F., Kumada T., Kim H. -D., Koga H., Vivaldi C., Solda C., Hiraoka A., Bang Y., Atsukawa M., Torimura T., Tsuj K., Itobayashi E., Toyoda H., Fukunishi S., Rimassa L., Rimini M., Cascinu S., Cucchetti A., Nakamura S., Michitaka K., Itokawa N., Hayama K., Hirooka M., Koizumi Y., Hiasa Y., Ishikawa T., Imai M., Takaguchi K., Tsutsui A., Nagano T., Kariyama K., Nouso K., Tajiri K., Shimada N., Shibata H., Ochi H., Joko K., Yasuda S., Ohama H., Kawata K.

المساهمون: Casadei-Gardini, A., Scartozzi, M., Tada, T., Yoo, C., Shimose, S., Masi, G., Lonardi, S., Frassineti, L. G., Nicola, S., Piscaglia, F., Kumada, T., Kim, H. -D., Koga, H., Vivaldi, C., Solda, C., Hiraoka, A., Bang, Y., Atsukawa, M., Torimura, T., Tsuj, K., Itobayashi, E., Toyoda, H., Fukunishi, S., Rimassa, L., Rimini, M., Cascinu, S., Cucchetti, A., Nakamura, S., Michitaka, K., Itokawa, N., Hayama, K., Hirooka, M., Koizumi, Y., Hiasa, Y., Ishikawa, T., Imai, M., Takaguchi, K., Tsutsui, A., Nagano, T., Kariyama, K., Nouso, K., Tajiri, K., Shimada, N., Shibata, H., Ochi, H., Joko, K., Yasuda, S., Ohama, H., Kawata, K.

مصطلحات موضوعية: extrahepatic disease, lenvatinib, performance status, sorafenib, survival, trans-arterial chemoembolization, Humans, Phenylurea Compounds, Probability, Quinolines, Antineoplastic Agents, Carcinoma, Hepatocellular, Liver Neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000651384000020; volume:41; issue:6; firstpage:1389; lastpage:1397; numberofpages:9; journal:LIVER INTERNATIONAL; http://hdl.handle.net/20.500.11768/125275Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85101158292

الإتاحة: https://doi.org/20.500.11768/125275Test
https://doi.org/10.1111/liv.14817Test
https://hdl.handle.net/20.500.11768/125275Test

المؤلفون: Casadei-Gardini A., Rimassa L., Rimini M., Yoo C., Ryoo B. -Y., Lonardi S., Masi G., Kim H. -D., Vivaldi C., Ryu M. -H., Rizzato M. D., Salani F., Bang Y., Pellino A., Catanese S., Burgio V., Cascinu S., Cucchetti A.

المساهمون: Casadei-Gardini, A., Rimassa, L., Rimini, M., Yoo, C., Ryoo, B. -Y., Lonardi, S., Masi, G., Kim, H. -D., Vivaldi, C., Ryu, M. -H., Rizzato, M. D., Salani, F., Bang, Y., Pellino, A., Catanese, S., Burgio, V., Cascinu, S., Cucchetti, A.

مصطلحات موضوعية: Cabozantinib, CELESTIAL, Hepatocellular carcinoma (HCC), Indirect treatment comparison, Matching-adjusted indirect comparison (MAIC), Regorafenib, RESORCE, Second-line, Systemic therapy, Targeted therapy, Adult, Aged, Anilides, Carcinoma, Hepatocellular, Clinical Trials, Phase III as Topic, Female, Humans, Liver Neoplasms, Male, Middle Aged, Phenylurea Compounds, Progression-Free Survival, Pyridines, Salvage Therapy, Sorafenib

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000630834000003; volume:147; issue:12; firstpage:3665; lastpage:3671; numberofpages:7; journal:JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY; http://hdl.handle.net/20.500.11768/125267Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85103171083

الإتاحة: https://doi.org/20.500.11768/125267Test
https://doi.org/10.1007/s00432-021-03602-wTest
https://hdl.handle.net/20.500.11768/125267Test

المؤلفون: Casadei Gardini, A, Marisi, G, Scarpi, E, Silvestris, N, Masi, G, Vivaldi, C, Brunetti, O, Tamberi, S, Foschi, FG, Tamburini, E, Tenti, E, Ricca Rosellini, S, Ulivi, P, Cascinu, S, Nanni, O, Frassineti, GL, SCARTOZZI, MARIO, FALOPPI, LUCA

المساهمون: Casadei Gardini, A, Marisi, G, Scarpi, E, Scartozzi, Mario, Faloppi, Luca, Silvestris, N, Masi, G, Vivaldi, C, Brunetti, O, Tamberi, S, Foschi, Fg, Tamburini, E, Tenti, E, Ricca Rosellini, S, Ulivi, P, Cascinu, S, Nanni, O, Frassineti, Gl

مصطلحات موضوعية: Diabetes, Hepatocellular carcinoma, Insulin, Metformin, Sorafenib, Antineoplastic agents, Carcinoma hepatocellular, Diabetes mellitus Type 2, Drug resistance neoplasm, Humans, Hypoglycemic agents, Liver neoplasms, Niacinamide, Phenylurea compounds, Protein kinase inhibitors, Retrospective studies, Survival analysis, Treatment outcome, Pharmacology (medical), Pharmacology, Medicine (all)

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/26513009; info:eu-repo/semantics/altIdentifier/wos/WOS:000367152600002; volume:16; issue:18; firstpage:2719; lastpage:2725; numberofpages:7; journal:EXPERT OPINION ON PHARMACOTHERAPY; http://hdl.handle.net/11584/187007Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84952720707

الإتاحة: https://doi.org/10.1517/14656566.2015.1102887Test
http://hdl.handle.net/11584/187007Test

المؤلفون: Marianna Silletta, V. Burgio, Gianluca Masi, A. Takata, M.G. Viola, Mario Domenico Rizzato, Kazuto Tajiri, H. Toyoda, M. Scartozzi, Francesca Salani, Syusuke Okamura, Francesco Giuseppe Foschi, Takashi Kumada, G. Astara, I.G. Rapposelli, Fabio Conti, Emiliano Tamburini, Claudia Campani, Kazuhito Kawata, Fabio Marra, A. Forgione, A. Hiraoka, Giovanni Luca Frassineti, R. Tortora, Takuji Torimura, Shigeo Shimose, Masahito Nakano, Masanori Atsukawa, Stefano Cascinu, Andrea Casadei-Gardini, H. Shibata, G.G. Di Costanzo, Caterina Vivaldi, Antonio Pellino, Claudia Angela Maria Fulgenzi, Toshifumi Tada, Eleonora Lai, Fabio Piscaglia, S. Lonardi, Margherita Rimini

المساهمون: Rapposelli, I. G., Shimose, S., Kumada, T., Okamura, S., Hiraoka, A., Di Costanzo, G. G., Marra, F., Tamburini, E., Forgione, A., Foschi, F. G., Silletta, M., Lonardi, S., Masi, G., Scartozzi, M., Nakano, M., Shibata, H., Kawata, K., Pellino, A., Vivaldi, C., Lai, E., Takata, A., Tajiri, K., Toyoda, H., Tortora, R., Campani, C., Viola, M. G., Piscaglia, F., Conti, F., Fulgenzi, C. A. M., Frassineti, G. L., Rizzato, M. D., Salani, F., Astara, G., Torimura, T., Atsukawa, M., Tada, T., Burgio, V., Rimini, M., Cascinu, S., Casadei-Gardini, A., Rapposelli I.G., Shimose S., Kumada T., Okamura S., Hiraoka A., Di Costanzo G.G., Marra F., Tamburini E., Forgione A., Foschi F.G., Silletta M., Lonardi S., Masi G., Scartozzi M., Nakano M., Shibata H., Kawata K., Pellino A., Vivaldi C., Lai E., Takata A., Tajiri K., Toyoda H., Tortora R., Campani C., Viola M.G., Piscaglia F., Conti F., Fulgenzi C.A.M., Frassineti G.L., Rizzato M.D., Salani F., Astara G., Torimura T., Atsukawa M., Tada T., Burgio V., Rimini M., Cascinu S., Casadei-Gardini A.

المصدر: ESMO Open

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, lenvatinib prognostic index, Carcinoma, Hepatocellular, hepatocellular carcinoma, recursive partitioning analysis, Humans, Phenylurea Compounds, Prognosis, Quinolines, Chemoembolization, Therapeutic, Liver Neoplasms, Recursive partitioning, Prognostic score, chemistry.chemical_compound, Internal medicine, medicine, Original Research, business.industry, Carcinoma, Treatment options, Hepatocellular, medicine.disease, chemistry, Hepatocellular carcinoma, Cohort, Chemoembolization, Therapeutic, Medium Risk, Lenvatinib, business

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c646c8ea42eb9869b7fe150f8d4da7b4Test
http://europepmc.org/articles/PMC8219999Test

المؤلفون: Andrea Casadei-Gardini, Margherita Rimini, Yeonghak Bang, Caterina Vivaldi, Min-Hee Ryoo, Mario Domenico Rizzato, Francesca Bergamo, Alessandro Granito, Francesca Salani, Luca Ielasi, Valentina Burgio, Hyung-Don Kim, Simona Leoni, Sara Lonardi, Gianluca Masi, Stefano Cascinu, Changhoon Yoo, Baek-Yeol Ryoo

المساهمون: Rimini, M., Yoo, C., Lonardi, S., Masi, G., Granito, A., Bang, Y., Rizzato, M. D., Vivaldi, C., Ielasi, L., Kim, H. -D., Bergamo, F., Salani, F., Leoni, S., Ryoo, B. -Y., Ryoo, M. -H., Burgio, V., Cascinu, S., Casadei-Gardini, A., Rimini M., Yoo C., Lonardi S., Masi G., Granito A., Bang Y., Rizzato M.D., Vivaldi C., Ielasi L., Kim H.-D., Bergamo F., Salani F., Leoni S., Ryoo B.-Y., Ryoo M.-H., Burgio V., Cascinu S., Casadei-Gardini A.

مصطلحات موضوعية: Phenylurea Compound, Sorafenib, Oncology, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, Prognosi, Pyridines, Pyridine, Population, Recursive partitioning, chemistry.chemical_compound, Regorafenib, Internal medicine, medicine, Humans, Pharmacology (medical), education, Univariate analysis, education.field_of_study, business.industry, Phenylurea Compounds, Liver Neoplasms, medicine.disease, Prognosis, Confidence interval, chemistry, Hepatocellular carcinoma, Cohort, business, Human, medicine.drug

وصف الملف: STAMPA

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4cfc7d916296dd1c3014b94162795ef9Test
http://hdl.handle.net/11568/1106994Test

المؤلفون: Andrea Casadei‐Gardini, Mario Scartozzi, Toshifumi Tada, Changhoon Yoo, Shigeo Shimose, Gianluca Masi, Sara Lonardi, Luca Giovanni Frassineti, Silvestris Nicola, Fabio Piscaglia, Takashi Kumada, Hyung‐Don Kim, Hironori Koga, Caterina Vivaldi, Caterina Soldà, Atsushi Hiraoka, Yeonghak Bang, Masanori Atsukawa, Takuji Torimura, Kunihiko Tsuj, Ei Itobayashi, Hidenori Toyoda, Shinya Fukunishi, Lorenza Rimassa, Margherita Rimini, Stefano Cascinu, Alessandro Cucchetti, Shinichiro Nakamura, Kojiro Michitaka, Norio Itokawa, Korenobu Hayama, Masashi Hirooka, Yohei Koizumi, Yoichi Hiasa, Toru Ishikawa, Michitaka Imai, Koichi Takaguchi, Akemi Tsutsui, Takuya Nagano, Kazuya Kariyama, Kazuhiro Nouso, Kazuto Tajiri, Noritomo Shimada, Hiroshi Shibata, Hironori Ochi, Kouji Joko, Satoshi Yasuda, Hideko Ohama, Kazuhito Kawata

المساهمون: Casadei-Gardini A., Scartozzi M., Tada T., Yoo C., Shimose S., Masi G., Lonardi S., Frassineti L.G., Nicola S., Piscaglia F., Kumada T., Kim H.-D., Koga H., Vivaldi C., Solda C., Hiraoka A., Bang Y., Atsukawa M., Torimura T., Tsuj K., Itobayashi E., Toyoda H., Fukunishi S., Rimassa L., Rimini M., Cascinu S., Cucchetti A., Nakamura S., Michitaka K., Itokawa N., Hayama K., Hirooka M., Koizumi Y., Hiasa Y., Ishikawa T., Imai M., Takaguchi K., Tsutsui A., Nagano T., Kariyama K., Nouso K., Tajiri K., Shimada N., Shibata H., Ochi H., Joko K., Yasuda S., Ohama H., Kawata K., Casadei-Gardini, A., Scartozzi, M., Tada, T., Yoo, C., Shimose, S., Masi, G., Lonardi, S., Frassineti, L. G., Nicola, S., Piscaglia, F., Kumada, T., Kim, H. -D., Koga, H., Vivaldi, C., Solda, C., Hiraoka, A., Bang, Y., Atsukawa, M., Torimura, T., Tsuj, K., Itobayashi, E., Toyoda, H., Fukunishi, S., Rimassa, L., Rimini, M., Cascinu, S., Cucchetti, A., Nakamura, S., Michitaka, K., Itokawa, N., Hayama, K., Hirooka, M., Koizumi, Y., Hiasa, Y., Ishikawa, T., Imai, M., Takaguchi, K., Tsutsui, A., Nagano, T., Kariyama, K., Nouso, K., Tajiri, K., Shimada, N., Shibata, H., Ochi, H., Joko, K., Yasuda, S., Ohama, H., Kawata, K.

مصطلحات موضوعية: Sorafenib, Oncology, medicine.medical_specialty, Carcinoma, Hepatocellular, Antineoplastic Agents, lenvatinib, survival, trans-arterial chemoembolization, law.invention, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Clinical endpoint, performance status, Humans, Adverse effect, Probability, Hepatology, Performance status, business.industry, Phenylurea Compounds, Carcinoma, Liver Neoplasms, Hepatocellular, medicine.disease, extrahepatic disease, sorafenib, Quinolines, chemistry, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, Cohort, 030211 gastroenterology & hepatology, Lenvatinib, business, medicine.drug, performance statu

وصف الملف: ELETTRONICO

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb1525de64e54068b735c079325a057eTest
http://hdl.handle.net/11568/1111033Test

المؤلفون: Hyung-Don Kim, Caterina Vivaldi, Francesca Salani, Martina Valgiusti, Ilario Giovanni Rapposelli, Changhoon Yoo, Stefano Cascinu, Yeonghak Bang, Baek-Yeol Ryoo, Min-Hee Ryu, Giovanni Luca Frassineti, Sook Ryun Park, Valentina Burgio, Sara Lonardi, Mario Domenico Rizzato, Margherita Rimini, Valentina Massa, Mario Scartozzi, Andrea Casadei-Gardini, Vittorina Zagonel

المساهمون: Bang, Y., Yoo, C., Lonardi, S., Kim, H. -D., Vivaldi, C., Rimini, M., Frassineti, G. L., Park, S. R., Rizzato, M. D., Ryu, M. -H., Salani, F., Rapposelli, I. G., Ryoo, B. -Y., Zagonel, V., Massa, V., Valgiusti, M., Burgio, V., Scartozzi, M., Cascinu, S., Casadei-Gardini, A.

المصدر: Targeted Oncology. 16:401-410

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Sorafenib, Cancer Research, medicine.medical_specialty, Carcinoma, Hepatocellular, Pyridines, Population, Placebo, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Internal medicine, Regorafenib, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Pharmacology (medical), Propensity Score, education, Survival analysis, Retrospective Studies, Univariate analysis, education.field_of_study, business.industry, Phenylurea Compounds, Liver Neoplasms, Retrospective cohort study, digestive system diseases, 030104 developmental biology, chemistry, 030220 oncology & carcinogenesis, Propensity score matching, Female, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9312ec95c91c2712f7170314a68430a0Test
https://doi.org/10.1007/s11523-021-00797-3Test